Lilly Just Placed Million Bet on Injectables Boom
Lilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
Learn how to turn your hobbies into income streams to manage credit card bills. Start monetizing today!
12,935 articlesLilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
Investors are weighing big potential against real-world risk. This article breaks down VK2735, market dynamics, and w...
Meta Platforms signals a cloud compute push, aiming to sell AI capacity directly to enterprises amid a record capex c...
CoreWeave surged after its IPO, then pulled back. This guide breaks down how to think about buying the dip, with real...
Dram stocks surged on AI-driven demand, yet the rally carries volatility and a stubborn supply gap. This analysis exp...
As 2026 unfolds, investors face a clear choice between Lilly's growth engine in big markets and Teva's value-forward ...
Cathie Wood is back in the IPO spotlight. This piece breaks down the three newly public names Ark Invest reportedly a...
In June, Netflix faced a sharp pullback as investors weighed slowing subscriber growth against rising content costs a...
Qualcomm unveils a bold AI-backed diversification plan led by CIO Attila Tinic, targeting data centers, automotive an...
AMD leads a chip stock rebound with a 7% jump, followed by Intel and Broadcom, as analysts frame the pullback as a bu...
A high-level insider move follows a strong stock run. This article breaks down what the CFO’s sale signals, how to re...
A high-profile insider sale at CoreWeave has sparked questions about the company’s trajectory. This guide explains wh...